Clinical Trials Logo

Other Preterm Infants clinical trials

View clinical trials related to Other Preterm Infants.

Filter by:

NCT ID: NCT01450436 Completed - Clinical trials for Other Preterm Infants

Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation)

EPIPOD
Start date: September 2011
Phase:
Study type: Observational

Neonatal nutritional management consists in reproducing miming uteri growth kinetic. Since the seventies, NICU (Neonatal Intensive Care Unit) strategy consists in a high proteidic input (apport) supposed to allow optimal neurodevelopment. However, nutritional practices and strategies have significantly evolved during these last years, influenced by Baker nutritional imprinting concept (2002). Actually, neonatal high proteidic exposition could perturb metabolism and hormonal systems of newborns conducting to a reinforcement of obesity and cardio-vascular pathology prevalence in this target population at adulthood. In this context many studies emerged since 2000 and try to assess the trade-off between neurodevelopment and growth under nutrition conditions. EPIPOD try to focus the link between heterogenous proteic input dispensed in our NICU (described by tercil methods on population) and fat mass phenotype variations at discharge (described by tercil methods); and its consequences on neurodevelopmental growth. Understanding how particular nutritional exposition could determine "fatty" phenotype and impact neurodevelopment is clearly our main goal.

NCT ID: NCT00233324 Completed - Premature Birth Clinical Trials

Surfactant Positive Airway Pressure and Pulse Oximetry Trial

SUPPORT
Start date: February 2005
Phase: Phase 3
Study type: Interventional

This study compared the use of continuous positive airway pressure initiated at birth with the early administration of surfactant administered through a tube in the windpipe within 1 hour of birth for premature infants born at 24 to 27 weeks gestation. In addition, these infants within 2 hours of birth, had a special pulse oximeter placed to continuously monitor their oxygen saturation in two different target ranges (85-89% or 91-95%). This study helped determine whether or not these two management strategies affect chronic lung disease and survival of premature infants.